BRIEF

on SPINEWAY (EPA:ALSPW)

Spineway legal proceedings against Strategos: new decision

Stock price chart of SPINEWAY (EPA:ALSPW) showing fluctuations.

Spineway, a spinal implant specialist, has lost a claim by the Delaware Court of Appeals, which upheld the dismissal of its request to enforce a favorable arbitration award. This decision comes after a dispute with Strategos over the acquisition of shares in Integral Medical Solutions. In 2022, a Geneva arbitration tribunal ruled in favor of Spineway, ordering Strategos to repay €4.16 million.

Despite the rejection by the first instance in March 2024, and then by the Court of Appeal in 2025, Spineway remains determined to have its rights recognized and is considering other legal avenues for the enforcement of the arbitral award.

R. P.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all SPINEWAY news